KEGG   DRUG: Budesonide, glycopyrronium bromide and formoterol fumarate
Entry
D11584            Mixture   Drug                                   
Name
Budesonide, glycopyrronium bromide and formoterol fumarate;
Budesonide, glycopyrrolate and formoterol fumarate;
Breztri (TN)
Product
BREZTRI (AstraZeneca Pharmaceuticals LP)
Component
Budesonide [DR:D00246], Glycopyrrolate [DR:D00540], (Formoterol fumarate hydrate [DR:D05277] | Formoterol fumarate [DR:D01373])
Remark
Therapeutic category: 2290
ATC code: R03AL11
Product: D11584<JP/US>
Efficacy
Bronchodilator
Interaction
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 R RESPIRATORY SYSTEM
  R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES
   R03A ADRENERGICS, INHALANTS
    R03AL Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids
     R03AL11 Formoterol, glycopyrronium bromide and budesonide
      D11584  Budesonide, glycopyrronium bromide and formoterol fumarate <JP/US>
USP drug classification [BR:br08302]
 Respiratory Tract/Pulmonary Agents
  Bronchodilator Combinations
   Budesonide/ Formoterol Fumarate/ Glycopyrrolate
    D11584  Budesonide, glycopyrronium bromide and formoterol fumarate
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  22  Respiratory organ agents
   229  Miscellaneous
    2290  Miscellaneous
     D11584  Budesonide, glycopyrronium bromide and formoterol fumarate
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D11584
New drug approvals in the USA, Europe and Japan [br08328.html]
 Approval dates by FDA, EMA and PMDA
  D11584
Other DBs
PubChem: 384585559
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system